Codeine-Guaifenesin
- Product NDC
- 68071-5173
- 11-digit product format
- 680715173
- Labeler code
- 68071
- Product ID
- 68071-5173_1b56a7bc-e859-d8c7-e063-6294a90a5ee1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Codeine Phosphate and Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-04-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 10; 100 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-5173-4 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-5173-4 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-5173-4 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Codeine-Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL |
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995868 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9e691264-d48a-6b48-e053-2995a90a9352 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5173-4 | 2024-06-25 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
| 68071-5173-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5173-4 | Codeine-Guaifenesin | 120 mL in 1 BOTTLE | SOLUTION | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5173 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240627_9e691264-d48a-6b48-e053-2995a90a9352.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pediacare Childrens Acetaminophen Grape | ACETAMINOPHEN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 596372c7-eca3-4527-8e22-ab0751e2526b | 2024-12-30 | Warnings | M013 |
| Bayer Genuine Aspirin | BAYER GENUINE ASPIRIN | Lil' Drug Store Products, Inc. | d17834d7-cb3e-6bf2-e053-2a95a90ae5c1 | 2024-12-30 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN 500 MG, FILM-COATED CAPLET | Lil' Drug Store Products, Inc. | e5fd2b46-683e-4cf5-e053-2995a90a5512 | 2024-12-30 | Warnings | M013 |
| Night Time Severe Cold and Cough Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Chain Drug Consortium, LLC | c8e9b57b-83e9-46c5-9791-02c4c2b94004 | 2024-12-29 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC. | 1608b4f0-bf20-4024-b8f2-20a4df7a4b21 | 2024-12-26 | Warnings | M013 |
| Aspirin | ASPIRIN | Advance Pharmaceutical Inc. | f6a9ea44-08b8-4a33-bfbd-68cb2d852c39 | 2024-12-26 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | cfc7eac3-35be-4002-b8ef-be1dfc8caf69 | 2024-12-26 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | a3031139-4709-43f2-95a8-89840c595f7f | 2024-12-26 | Warnings | M013 |
| Acetaminophen 250mg Aspirin 250mg Caffeine 65mg | ACETAMINOPHEN 250MG ASPIRIN 250MG CAFFEINE 65MG | WALGREENS CO. | 98bb28ed-d146-ca3d-e053-2a95a90a9eaf | 2024-12-26 | Warnings | M013 |
| Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg | ACETAMINOPHEN 500MG CAFFEINE 60MG PYRILAMINE MALEATE 15MG | WALGREENS CO. | 982faa74-d498-cd1e-e053-2995a90afa1e | 2024-12-25 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 11bf6e1b-aed9-4f8f-9f03-ea911ae9f702 | 2024-12-23 | Warnings | M013 |
| Rugby Regular Strength Acetaminophen | ACETAMINOPHEN | RUGBY LABORATORIES | 295b0d00-4d4a-405f-9325-d01c5d4f3ed4 | 2024-12-20 | Warnings | M013 |
| Walgreens Pain Relief Powder | ASPIRIN AND CAFFEINE | Walgreens Co. | 61493d34-2432-4683-9b32-e1851a4337be | 2024-12-18 | Warnings | M013 |
| Reese Headache Powders | ASPIRIN AND CAFFEINE | Reese Pharmaceutical Co | 386f7a6c-4bfc-4140-a67b-07f6b520d58f | 2024-12-18 | Warnings | M013 |
| NobleAid PAIN RELIEVER | ASPIRIN | Noble Otc LLC | aa08e488-2f69-4d7e-86ba-ccfad563edcf | 2024-12-18 | Warnings | M013 |
| Dollar General Headache Powders | ASPIRIN AND CAFFEINE | Dolgencorp, LLC | 11b0271b-d65c-49c4-a081-d71044a0e04c | 2024-12-18 | Warnings | M013 |
| Family Wellness Pain Relief Powder | ASPIRIN AND CAFFEINE | Family Dollar Services Inc | b2e55de7-3c36-49cc-8f7f-1013fd1ec359 | 2024-12-18 | Warnings | M013 |
| Best Choice Pain Relief Powder | ASPIRIN AND CAFFEINE | Value Merch | a95b9b22-ea5c-4a02-b35d-c8ae1e117604 | 2024-12-18 | Warnings | M013 |
| Walmart Pain Relief Powder | ASPIRIN AND CAFFEINE | Walmart | c69aa61f-6a74-40a3-8737-195fa545e261 | 2024-12-18 | Warnings | M013 |
| Quality Choice Pain Relief Powder | ASPIRIN AND CAFFEINE | Chain Drug Marketing Association | 8e1f4057-4968-4523-9b3f-55aea421b674 | 2024-12-18 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995868 | codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5173-4 | 68071517304 | 120 mL in 1 BOTTLE (68071-5173-4) | 120 ml | 2020-02-12 | 0000-00-00 | No | No | Current |